Carlos Neideck

Carlos Neideck

Auto-generated profile, based on publicly available information

Carlos Neideck

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PHPhilipp von Hundelshausen
Philipp von Hundelshausen
SAStijn M. Agten
Stijn M. Agten
VEVeit Eckardt
Veit Eckardt
XBXavier Blanchet
Xavier Blanchet
MSMartin M. Schmitt
Martin M. Schmitt
CWChristian Weber
Christian Weber
Functional synergism and inhibitory effects of chemokine heterodimers can be selectively targeted by specific peptides in models of inflammation.

6 June 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
LOLiliana Osório
Liliana Osório
XWXuewei Wu
Xuewei Wu
LWLinsheng Wang
Linsheng Wang
ZJZhixin Jiang
Zhixin Jiang
CNCarlos Neideck
Carlos Neideck
ZZZhongjun Zhou
Zhongjun Zhou
Isthmin1 (ISM1) was originally identified as a fibroblast group factor expressed in Xenopus laevis embryonic brain, but its biological functions remain unclear. The spatiotemporal distribution of ISM1, with high expression in the anterior primitive streak of the chick embryo and the anterior mesendoderm of the mouse embryo, suggested that ISM1 may regulate signaling by the NODAL subfamily of TGB-β cytokines that control embryo patterning. We report that ISM1 is an inhibitor of NODAL signaling. ISM1 has little effect on TGF-β1, ACTIVIN-A, or BMP4 signaling but specifically inhibits NODAL-induced phosphorylation of SMAD2. In line with this observation, ectopic ISM1 causes defective left-right asymmetry and abnormal heart positioning in chick embryos. Mechanistically, ISM1 interacts with NODAL ligand and type I receptor ACVR1B through its AMOP domain, which compromises the NODAL–ACVR1B interaction and down-regulates phosphorylation of SMAD2. Therefore, we identify ISM1 as an extracellular antagonist of NODAL and reveal a negative regulatory mechanism that provides greater plasticity for the fine-tuning of NODAL signaling.